Jason Farley

Professor

20042020
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Dive into the research topics where Jason Farley is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 4 Similar Profiles
HIV Medicine & Life Sciences
Multidrug-Resistant Tuberculosis Medicine & Life Sciences
South Africa Medicine & Life Sciences
Methicillin-Resistant Staphylococcus aureus Medicine & Life Sciences
Nurses Medicine & Life Sciences
Tuberculosis Medicine & Life Sciences
HIV Infections Medicine & Life Sciences
Infection Control Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2004 2020

HIV drug resistance in a cohort of HIV-infected MSM in the United States

Fogel, J. M., Sivay, M. V., Cummings, V., Wilson, E. A., Hart, S., Gamble, T., Laeyendecker, O., Fernandez, R. E., Del Rio, C., Batey, D. S., Mayer, K. H., Farley, J. E., McKinstry, L., Hughes, J. P., Remien, R. H., Beyrer, C. & Eshleman, S. H., Jan 1 2020, In : AIDS (London, England). 34, 1, p. 91-101 11 p.

Research output: Contribution to journalArticle

Drug Resistance
Integrases
HIV
Baltimore
Tenofovir

Acceptability of self-collecting oropharyngeal swabs for sexually transmissible infection testing among men and women

Dangerfield, D., Farley, J., Holden, J., Barnes, M., Barnes, P., Jett-Goheen, M. & Gaydos, C. A., Jan 1 2019, In : Sexual Health.

Research output: Contribution to journalArticle

Infection
Chlamydia
Gonorrhea
Sexually Transmitted Diseases
HIV Infections

Adverse outcome pathway for aminoglycoside ototoxicity in drug-resistant tuberculosis treatment

Hong, H., Dooley, K. E., Starbird, L. E., Francis, H. W. & Farley, J., Jan 1 2019, In : Archives of Toxicology.

Research output: Contribution to journalArticle

Multidrug-Resistant Tuberculosis
Aminoglycosides
Audition
Hearing Loss
Oxidative stress
Multidrug-Resistant Tuberculosis
Cardiovascular Diseases
Cross-Sectional Studies
Diabetes Mellitus
South Africa

Evaluation of miLINC to shorten time to treatment for rifampicinresistant Mycobacterium tuberculosis

Farley, J. E., McKenzie-White, J., Bollinger, R., Hong, H., Lowensen, K., Chang, L. W., Stamper, P., Berrie, L., Olsen, F., Isherwood, L., Ndjeka, N. & Stevens, W., Sep 1 2019, In : International Journal of Tuberculosis and Lung Disease. 23, 9, p. 980-988 9 p.

Research output: Contribution to journalArticle

Mycobacterium tuberculosis
Tuberculosis
Rifampin
Therapeutics
Mobile Applications